Mapping of novel peptides of WT-1 and presenting HLA alleles that induce epitope-specific HLA-restricted T cells with cytotoxic activity against WT-1(+) leukemias.
about
Adoptive T-cell therapy for LeukemiaTherapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1.A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemiasGeneration of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplantGeneration of tumor antigen-specific T cell lines from pediatric patients with acute lymphoblastic leukemia--implications for immunotherapy.Affinity maturation of T-cell receptor-like antibodies for Wilms tumor 1 peptide greatly enhances therapeutic potential.Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia.Generation of a cord blood-derived Wilms Tumor 1 dendritic cell vaccine for AML patients treated with allogeneic cord blood transplantation.WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptidesAdoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activityA High-avidity WT1-reactive T-Cell Receptor Mediates Recognition of Peptide and Processed Antigen but not Naturally Occurring WT1-positive Tumor Cells.Immunotherapy for pediatric leukemia.Co-administration of α-GalCer analog and TLR4 agonist induces robust CD8(+) T-cell responses to PyCS protein and WT-1 antigen and activates memory-like effector NKT cellsAdoptive Immunotherapy For Leukemia With Ex vivo Expanded T Cells.CAR T cells for acute myeloid leukemia: the LeY of the land.WT1-specific T-cell responses in high-risk multiple myeloma patients undergoing allogeneic T cell-depleted hematopoietic stem cell transplantation and donor lymphocyte infusions.T-cell depleted allogeneic hematopoietic cell transplants as a platform for adoptive therapy with leukemia selective or virus-specific T-cells.An immunogenic WT1-derived peptide that induces T cell response in the context of HLA-A*02:01 and HLA-A*24:02 molecules.A new method to monitor antigen-specific CD8+ T cells, avoiding additional target cells and the restriction to human leukocyte antigen haplotype.BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors.Highlights of the third International Conference on Immunotherapy in Pediatric Oncology.Targeting of the WT191-138 fragment to human dendritic cells improves leukemia-specific T-cell responses providing an alternative approach to WT1-based vaccination.Human herpesvirus 6B immediate-early I protein contains functional HLA-A*02, HLA-A*03, and HLA-B*07 class I restricted CD8(+) T-cell epitopes.In situ loading of skin dendritic cells with apoptotic bleb-derived antigens for the induction of tumor-directed immunity.Cell therapies for hematological malignancies: don't forget non-gene-modified t cells!Induction of anti-leukemic responses by stimulation of leukemic CD3+ cells with allogeneic stimulator cells
P2860
Q27006934-E70C11DE-3BFB-486D-93D7-4EF922D00475Q27313856-2B056416-1621-4D09-84D6-2EA2A2EFEA91Q33714727-91A2D3C7-A3D9-4460-A48F-0B51148DE405Q34635978-19B53C31-B8E4-4380-B889-2E7BD1B91C4DQ34803707-68F4CB61-4398-4D94-B3BC-82402BCC39EAQ35634680-E7015B3F-565A-4630-94DD-783B8ED805DFQ35958223-2C6BD8E3-7F40-4A07-8EDA-936DB4C18B31Q36107961-8108694C-B8AA-4ADD-AE81-B39907CD1693Q36198150-B46F8351-8322-42BF-A325-20FADCF46FAAQ36891101-CCFCED0D-694A-4AEE-8CE2-F1706957C93EQ36943923-A7E25E88-FC95-4C43-A662-6C81DC1B08FAQ36968163-B7E3D9CE-B4C8-4412-A23D-EB438051636DQ37083610-F047C69E-93B0-4B4C-A3D8-0BC3853E6D49Q37242561-618BA7B0-11F4-41D4-ADAA-5674F02FCC1EQ37316892-C614FBD2-813F-427A-B867-5A51EE835567Q37635023-A9DD6AB1-52B6-488F-B01C-D6D890B0F89FQ38514497-E9C3AA29-33D4-4257-B49C-68D210D150D7Q38739446-5F807001-3BC2-4BEB-84B0-A9F069C88DC8Q38897933-EAD9B54C-E4E4-4C1D-95F3-4EEA02938AA5Q39122060-3256410D-E0FF-448A-AD41-31C762A8ADF1Q39403785-0E9225BE-B4CB-498A-AA7E-B9E68A93BFD7Q40452198-EF6E1C65-9E21-4F13-A76E-EF6E97477B4CQ41730520-0DC68A8D-6DA3-43AA-87C8-5E72974DAE33Q42172636-EC416EAD-4D34-47F7-B48F-D218CDD2F296Q47289766-D3BB6432-C216-444B-84D1-766047A30C61Q57483649-DBD98A97-6C1B-468A-AD86-31C9F3E83D4D
P2860
Mapping of novel peptides of WT-1 and presenting HLA alleles that induce epitope-specific HLA-restricted T cells with cytotoxic activity against WT-1(+) leukemias.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Mapping of novel peptides of W ...... ity against WT-1(+) leukemias.
@ast
Mapping of novel peptides of W ...... ity against WT-1(+) leukemias.
@en
type
label
Mapping of novel peptides of W ...... ity against WT-1(+) leukemias.
@ast
Mapping of novel peptides of W ...... ity against WT-1(+) leukemias.
@en
prefLabel
Mapping of novel peptides of W ...... ity against WT-1(+) leukemias.
@ast
Mapping of novel peptides of W ...... ity against WT-1(+) leukemias.
@en
P2093
P2860
P1433
P1476
Mapping of novel peptides of W ...... ity against WT-1(+) leukemias.
@en
P2093
Aisha Hasan
Annamalai Selvakumar
Dmitry Pankov
Ekaterina Doubrovina
Richard J O'Reilly
Taissia Carpenter
P2860
P304
P356
10.1182/BLOOD-2011-11-394619
P407
P50
P577
2012-05-23T00:00:00Z